T-LYMPHOBLASTIC LYMPHOMA
Clinical trials for T-LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for T-LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy aims to stop deadly childhood leukemia from coming back
Disease control Not yet recruitingThis early-phase trial tests a new treatment called CD7 CAR-T cell therapy in 10 children with high-risk T-cell leukemia or lymphoma. After standard chemotherapy puts the cancer into remission, the child's own immune cells are collected, modified to better attack cancer cells, an…
Matched conditions: T-LYMPHOBLASTIC LYMPHOMA
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 17, 2026 07:37 UTC
-
New combo therapy aims to boost survival in young blood cancer patients
Disease control Not yet recruitingThis study tests whether adding daratumumab, a drug that helps the immune system attack cancer cells, to standard chemotherapy can improve outcomes for children and young adults with newly diagnosed T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma. About 1,700…
Matched conditions: T-LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2, PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 17, 2026 07:34 UTC